HOME >> BIOLOGY >> NEWS
Prior caesarean delivery not linked to increased risk of stillbirth

Women with a history of caesarean section deliveries do not have a higher risk of a subsequent stillbirth, according to researchers at Yale School of Medicine and Columbia University.

Yale Obstetrics and Gynecology scientist Mert Ozan Bahtiyar, M.D., presented the findings today at the annual meeting of the Society for Maternal Fetal Medicine, held February 7-12 in Reno, Nevada.

"Caesarean sections have been associated with some pregnancy complications, but when a physician consults a woman with prior caesarean sections about her next pregnancy, stillbirth should not be one of the concerns," said Bahtiyar.

Fetal death or stillbirth is an underappreciated problem, according to Bahtiyar, who said that stillbirths account for more perinatal deaths than do complications of prematurity or sudden infant death syndrome. Some risk factors for stillbirth include history of a prior stillbirth, a mother over the age of 35, smoking, substance abuse, and underlying medical conditions such as diabetes, hypertension or preeclampsia. A previous study by researchers in England found that prior caesarean delivery was also a factor in increased risk of stillbirth.

Bahtiyar and his team decided to confirm the previous study using U.S. data from the Centers for Disease Control and Prevention's combined birth and death certificates from 1995 to 1997. They used a statistical analysis method called Cochran-Mantel-Haenszel to determine the odds of fetal death after prior caesarean section.

"We used a much larger data set of 250,000 patients than the British study, which used 16,000 patients," said Bahtiyar. "We were not expecting different results, but we found that prior caesarean section did not increase the risk of future stillbirth."

Co-authors included Joshua Copel, M.D., Charles J. Lockwood, M.D., and Errol R. Norwitz, M.D., of Yale; and Julian Robinson, M.D., Lambert Lumey, M.D., and Patricia Zybert, M.D., of Columbia.
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
12-Feb-2005


Page: 1 2

Related biology news :

1. Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
2. Gene therapy delivery of nerve growth factors reverses erectile dysfunction in animal model
3. New designer lipid-like peptide with lipid nanostructures for drug delivery systems
4. Alcohol use during pregnancy leads to greater risk of extreme preterm delivery
5. BEMA Fentanyl demonstrates substantial transmucosal delivery
6. Little lifesavers -- Nanoparticles improve delivery of medicines and diagnostics
7. Polymers show promise for gene delivery, tissue scaffolds, other biomedical applications
8. Nanoparticles for delivery of prostate cancer treatment
9. LED array signals successful binding of drug-delivery molecules to DNA
10. Pregnancy news -- Preterm delivery risk reduced by high-dose progesterone treatment
11. ResearchChannel expands delivery for its extensive online video library

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2016)... 2016  higi, the leading retail and omni-channel community ... web and mobile, today announced it has closed ... investors. --> --> ... innovate higi,s health platform – its network of ... including expanding services and programs to retail partners ...
(Date:1/8/2016)... OXFORD, Connecticut , January 8, 2016 ... growing m-commerce market and WorldVentures ® , a privately ... memberships and an Inc. 5000 fastest-growing company ... a strategic investment of $2 million in Nxt-ID to ... members based on Nxt-ID,s Wocket ® , a unique ...
(Date:1/7/2016)... , Jan. 7, 2016 Various factors ... biopharmaceutical products such as biologics and biosimilars. Some ... reduce healthcare expenditure, growing demand for cost-effective alternatives, ... population. Biosimilars are similar versions of their corresponding ... to their quality, safety, and efficacy. The global ...
Breaking Biology News(10 mins):
(Date:2/3/2016)...  With the growing need for better therapeutics, ... therapies such as monoclonal antibodies, recombinant protein therapeutics ... indications are in high demand. Conventionally expression systems ... production of these therapeutics. However, due to issues ... novel approaches and novel expression systems are currently ...
(Date:2/3/2016)... Mass., Feb. 3, 2016 Harvard Apparatus ... biotechnology company developing bioengineered organ implants for life-threatening ... announced that CEO Jim McGorry , will ... Conference on Tuesday, February 9, 2016 at ... City . HART,s presentation will be webcast ...
(Date:2/3/2016)... ... February 03, 2016 , ... ... a new office dedicated to the North American healthcare market. , Aerocom Healthcare, ... healthcare facilities. The company will provide new pneumatic tube systems or expand ...
(Date:2/3/2016)... CA (PRWEB) , ... February 03, 2016 , ... ... of remote Linux and Unix visualization solutions today announced the addition of a ... Preview allows users to see the current state of the remote Linux desktop ...
Breaking Biology Technology:
Cached News: